Tom Gevers

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline

Koen Andries, Cristina Villellas, Nele Coeck et al. · PLoS ONE · 2014 · 431 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus

Koen Andries, Marc Moeremans, Tom Gevers et al. · Antiviral Research · 2003 · 116 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Pharmacokinetics and Pharmacodynamics of TMC207 and Its <i>N</i> -Desmethyl Metabolite in a Murine Model of Tuberculosis

M.C. Rouan, Nacer Lounis, Tom Gevers et al. · Antimicrobial Agents and Chemotherapy · 2011 · 113 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet et al. · Journal of Medicinal Chemistry · 2008 · 100 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

Dirk Roymans, Hendrik L. De Bondt, Éric Arnoult et al. · Proceedings of the National Academy of Sciences · 2009 · 90 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14